title: [Breast cancer - Treatment guidelines and new treatment options in 2012, a medical oncology prospective].
abstract: Breast cancer is the leading cancer in women with an annual incidence rate of 110/100.000 women in all age groups in Europe. The incidence rate increases in older women. Treatment includes surgery, radiotherapy, chemotherapy with or without antibody therapy and hormonal treatment. During the last 40 years the survival rate has significantly improved. From the 1970ies to 2010 the five year survival rate has risen from 85% to 98% early breast cancer. Similarly, in metastatic breast cancer 5-year survival has increased from below 10% in 1970 to 26% in 2010. This was possible because of better treatment options and better screening causing earlier diagnosis of breast cancer. This article reviews the standard treatment of breast cancer according to ESMO/ASCO guidelines and discusses new treatment options and new therapeutic strategies for breast cancer.
authors.affiliation: Medizinische Onkologie, Universitätsspital Basel.
authors.forename: M
authors.initials: M
authors.lastname: Vetter
authors.forename: C
authors.initials: C
authors.lastname: Rochlitz
mesh_terms: D001943:Breast Neoplasms / Q000601:surgery; D005060:Europe; D006801:Humans; D008495:Medical Oncology; D011446:Prospective Studies; D015996:Survival Rate